IP Library › Assignment 060140/0236
Patent Assignment
Reel/Frame 060140/0236

Merger

Recorded: 2022-06-08 Pages: 9
Assignor
TOLERO PHARMACEUTICALS, INC.
Executed: 2020-07-01
Assignee
BOSTON BIOMEDICAL, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property (1)
Treatment of Acute Myeloid Leukemia (AML) with Venetoclax Failure
Application: 17/435,264 →
Publication: US 2022/0125776
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059809/0557 →
Assignment of Assignor's Interest Jun 8, 2022
From: ANTHONY, STEPHEN PATRICK; BEARSS, DAVID J.; MCCULLAR, MICHAEL VINCENT; SMITH, SUSAN CAROL
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 060140/0108 →
Change of Name Jun 8, 2022
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 060314/0505 →